Connor, Clark & Lunn Investment Management (CC&L)’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-106,500
| Closed | -$316K | – | 1071 |
|
|
2016
Q3 | $316K | Hold |
106,500
| – | – | ﹤0.01% | 666 |
|
|
2016
Q2 | $159K | Buy |
106,500
+33,900
| +47% | +$50.6K | ﹤0.01% | 767 |
|
|
2016
Q1 | $269K | Sell |
72,600
-4,900
| -6% | -$18.2K | ﹤0.01% | 670 |
|
|
2015
Q4 | $783K | Buy |
77,500
+6,600
| +9% | +$66.7K | 0.01% | 477 |
|
|
2015
Q3 | $964K | Buy |
+70,900
| New | +$964K | 0.01% | 411 |
|
|
2014
Q1 | – | Sell |
-10,150
| Closed | -$765K | – | 830 |
|
|
2013
Q4 | $765K | Sell |
10,150
-2,500
| -20% | -$188K | 0.01% | 423 |
|
|
2013
Q3 | $1.12M | Sell |
12,650
-1,900
| -13% | -$167K | 0.01% | 254 |
|
|
2013
Q2 | $972K | Buy |
+14,550
| New | +$972K | 0.01% | 267 |
|